Hirokazu Taniguchi - Concepedia

Author

Hirokazu Taniguchi

Also Known As

Benita Kiat Tee Tan, Daiki Ogawara, Donghui Tan, H TANIGUCHI, H Taniguchi, H. Taniguchi, HIROAKI TANIGUCHI, HIROKAZU TANIGUCHI, Haruko TANIGUCHI, Hirokazu TANIGUCHI

257

Publications

9.3K

Citations

H-Index

Concepts

All Affiliations

Nagasaki University National Cancer Center Hospital East Memorial Sloan Kettering Cancer Center Kanazawa University Tokyo National Hospital

About

Hirokazu Taniguchi is an author at Nagasaki University specializing in medicine, pathology, and tumor microenvironment.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	23	1.1K
2	Health Sciences	2	2	382
3	Allergy	2	2	57
4	Engineering	1	1	100
5	Natural Sciences	1	1	40

Hirokazu Taniguchi

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells Hirokazu Taniguchi, Tadaaki Yamada, Rong Wang, Nature Communications	2019	351
Feasibility and utility of a panel testing for 114 cancer‐associated genes in a clinical setting: A hospital‐based study Kuniko Sunami, Hitoshi Ichikawa, Takashi Kubo, Cancer Science Actionable Gene AberrationsCancer PathologyHospital‐based StudyGenetic EpidemiologyPathology	2019	351
Functional Characterization of Rat Brain-specific Organic Anion Transporter (Oatp14) at the Blood-Brain Barrier Daisuke Sugiyama, Hiroyuki Kusuhara, Hirokazu Taniguchi, Journal of Biological Chemistry	2003	280
Divergent mutational processes distinguish hypoxic and normoxic tumours Vinayak Bhandari, Constance H. Li, Robert G. Bristow, Nature Communications	2020	141
WEE1 inhibition enhances the antitumor immune response to PD-L1 blockade by the concomitant activation of STING and STAT1 pathways in SCLC Hirokazu Taniguchi, Rebecca Caeser, Shweta S. Chavan, Cell Reports	2022	123
Sex differences in oncogenic mutational processes Constance H. Li, Stephenie D. Prokopec, Ren Sun, Nature Communications	2020	122
Targeting Lysine-Specific Demethylase 1 Rescues Major Histocompatibility Complex Class I Antigen Presentation and Overcomes Programmed Death-Ligand 1 Blockade Resistance in SCLC Evelyn M. Nguyen, Hirokazu Taniguchi, Joseph M. Chan, Journal of Thoracic Oncology HistocompatibilityImmunogeneticsImmunologyAntigen ProcessingAutoimmunity	2022	114
Transient IGF-1R inhibition combined with osimertinib eradicates AXL-low expressing EGFR mutated lung cancer Rong Wang, Tadaaki Yamada, Kenji Kita, Nature Communications	2020	112
ONO-7475, a Novel AXL Inhibitor, Suppresses the Adaptive Resistance to Initial EGFR-TKI Treatment in <i>EGFR</i> -Mutated Non–Small Cell Lung Cancer Naoko Okura, Naoya Nishioka, Tadaaki Yamada, Clinical Cancer Research	2020	108
Automated histological classification of whole-slide images of gastric biopsy specimens Hiroshi Yoshida, Taichi Shimazu, Tomoharu Kiyuna, Gastric Cancer Image AnalysisEngineeringMedical ImagingDigital PathologyHistopathology	2017	100

Page 1